Clinical Trials Browser

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Neoplasms, Neoplasms by Site, Recurrence, Urogenital Neoplasms, Urologic Diseases

NCT04917809 2025-09-10

A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer

Phase 2 Active not recruiting

20 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT04179162 2025-06-13

Bacillus Calmette-Guérin (BCG) and Gemcitabine in People With High-Grade Non-Muscle Invasive Bladder Cancer That Came Back After BCG Treatment

Phase 1/2 Active not recruiting

54 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT04811846 2024-12-09

CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood

Phase NA Active not recruiting

40 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplastic Cells, Circulating, Neoplasms, Urogenital Neoplasms

NCT04167631 2024-10-30

Can VI-RADS/ADC Accurately Stage Bladder Cancer??

Phase NA Active not recruiting

150 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Diseases, Urinary Bladder Neoplasms

NCT04100733 2023-06-01

SEALS Xpert

Phase NA Active not recruiting

392 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

Clinical Trials

BladMetrix

Study of CG0070 After Transurethral Resection in Patients With IR NMIBC

CRUCIAL-R

NMIBC

GEMDOCE

CISTO

A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer

Bacillus Calmette-Guérin (BCG) and Gemcitabine in People With High-Grade Non-Muscle Invasive Bladder Cancer That Came Back After BCG Treatment

CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood

Can VI-RADS/ADC Accurately Stage Bladder Cancer??

SEALS Xpert